{"nct_id":"NCT01978093","title":"Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age","status":"COMPLETED","status_verified_date":"2018-08","start_date":"2014-02-01","start_date_type":null,"primary_completion_date":"2016-03-18","primary_completion_date_type":"ACTUAL","completion_date":"2016-03-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}